Quantifying the Value of Perfect Information in Emergency Vaccination Campaigns

PLoS Computational Biology

Volumn 13, Issue 2, 2017, Pages

  Bradbury, Naomi V ^a,b   Probert, William J M ^a,b   Shea, Katriona ^c,d   Runge, Michael C ^e   Fonnesbeck, Christopher J ^f   Keeling, Matt J ^b   Ferrari, Matthew J ^c,d   Tildesley, Michael J ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e PATUXENT WILDLIFE RESEARCH CENTER   (United States)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRICULTURE; COSTS; DELAY CONTROL SYSTEMS; DISEASE CONTROL; DISEASES; VACCINES;

DISEASE OUTBREAKS; ECONOMIC COSTS; EXPECTED VALUES; FOOT AND MOUTH DISEASE; MANAGEMENT OBJECTIVES; PERFORMANCE; UNCERTAINTY; VACCINE EFFICACIES; VALUE OF INFORMATION; VALUE OF PERFECT INFORMATION;

DECISION MAKING;

ALTERNATIVE MEDICINE; ARTICLE; CLINICAL DECISION MAKING; COST CONTROL; COST OF ILLNESS; DISEASE DURATION; EMERGENCY VACCINATION CAMPAIGN; EPIDEMIC; FOOT AND MOUTH DISEASE; HEALTH CARE PLANNING; HEALTH CARE POLICY; IMMUNITY; INFECTION CONTROL; LIVESTOCK; MEDICAL INFORMATION; UNITED KINGDOM; VACCINATION; ANIMAL; ANIMAL CULLING; COST BENEFIT ANALYSIS; ECONOMICS; EMERGENCY HEALTH SERVICE; FOOT-AND-MOUTH DISEASE; HEALTH CARE COST; HEALTH SURVEY; MASS IMMUNIZATION; PREVALENCE; PREVENTIVE HEALTH SERVICE; PROCEDURES; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; UTILIZATION;

VIRUS VACCINE;

ANIMAL CULLING; ANIMALS; COST-BENEFIT ANALYSIS; EMERGENCY MEDICAL SERVICES; FOOT-AND-MOUTH DISEASE; HEALTH CARE COSTS; IMMUNIZATION PROGRAMS; MASS VACCINATION; POPULATION SURVEILLANCE; PREVALENCE; RISK ASSESSMENT; UNITED KINGDOM; VIRAL VACCINES;

EID: 85014224162     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1005318     Document Type: Article

References (27)

1. Keeling MJ, Woolhouse MEJ, Shaw DJ, Matthews L, Chase-Topping M, Haydon DT, et al. Dynamics of the 2001 UK Foot and Mouth Epidemic: Stochastic Dispersal in a Heterogeneous Landscape. Science. 2001Oct26;294(5543):813–7. doi: 10.1126/science.106597311679661
2. Ferguson NM, Donnelly CA, Anderson RM, The foot-and-mouth epidemic in Great Britain: pattern of spread and impact of interventions. Science. 2001;292(5519):1155–60. doi: 10.1126/science.106102011303090
3. Morris RS, Stern MW, Stevenson MA, Wilesmith JW, Sanson RL, Predictive spatial modelling of alternative control strategies for the foot-and-mouth disease epidemic in Great Britain, 2001. Vet Rec. 2001Aug4;149(5):137–44. 11517981
4. Yokota F, Thompson KM, Value of information literature analysis: a review of applications in health risk management. Med Decis Making. 2004;24(3):287–98. doi: 10.1177/0272989X0426315715155018
5. Runge MC, Converse SJ, Lyons JE, Which uncertainty? Using expert elicitation and expected value of information to design an adaptive program. Biol Conserv. 2011;144(4):1214–23.
6. Shea K, Tildesley MJ, Runge MC, Fonnesbeck CJ, Ferrari MJ, Adaptive management and the value of information: Learning via intervention in epidemiology. PLoS Biol. 2014;12(10):e1001970. doi: 10.1371/journal.pbio.100197025333371
7. Cox LA, Popken DA, VanSickle JJ, Sahu R, Optimal Tracking and Testing of US and Canadian Herds for BSE: A Value-of-Information (VOI) Approach. Risk Anal. 2005;25(4):827–40. doi: 10.1111/j.1539-6924.2005.00648.x16268932
8. De Gourville E, Duintjer Tebbens RJ, Sangrujee N, Pallansch MA, Thompson KM, Global Surveillance and the Value of Information: The Case of the Global Polio Laboratory Network. Risk Anal. 2006Dec1;26(6):1557–69. doi: 10.1111/j.1539-6924.2006.00845.x17184397
9. Keeling MJ, Models of foot-and-mouth disease. Proc R Soc Lond B Biol Sci. 2005Jun22;272(1569):1195–202.
10. Anderson I. Foot and Mouth Disease 2001: Lessons to be Learned Inquiry Report. 2002.
11. Knight-Jones T, Rushton J, The economic impacts of foot and mouth disease–What are they, how big are they and where do they occur?Prev Vet Med. 2013;112(3):161–73.
12. Keeling MJ, Woolhouse MEJ, May RM, Davies G, Grenfell BT, Modelling vaccination strategies against foot-and-mouth disease. Nature. 2003Jan9;421(6919):136–42. doi: 10.1038/nature0134312508120
13. Tildesley MJ, Savill NJ, Shaw DJ, Deardon R, Brooks SP, Woolhouse ME, et al. Optimal reactive vaccination strategies for a foot-and-mouth outbreak in the UK. Nature. 2006;440(7080):83–6. doi: 10.1038/nature0432416511494
14. Roche S, Garner M, Sanson R, Cook C, Birch C, Backer J, et al. Evaluating vaccination strategies to control foot-and-mouth disease: a model comparison study. Epidemiol Infect. 2015;143(06):1256–75.
15. Paté-Cornell ME, Uncertainties in risk analysis: Six levels of treatment. Reliab Eng Syst Saf. 1996;54(2):95–111.
16. Regan HM, Colyvan M, Burgman MA, A taxonomy and treatment of uncertainty for ecology and conservation biology. Ecol Appl. 2002;12(2):618–28.
17. Knight-Jones TJD, Bulut AN, Gubbins S, Stärk KDC, Pfeiffer DU, Sumption KJ, et al. Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey. Vaccine. 2014;32(16):1848–55. doi: 10.1016/j.vaccine.2014.01.07124530150
18. Probert WJM, Shea K, Fonnesbeck CJ, Runge MC, Carpenter TE, Dürr S, et al. Decision-making for foot-and-mouth disease control: Objectives matter. Epidemics. 2016Jun;15:10–9. doi: 10.1016/j.epidem.2015.11.00227266845
19. Halasa T, Boklund A, Cox S, Enøe C, Meta-analysis on the efficacy of foot-and-mouth disease emergency vaccination. Prev Vet Med. 2011Jan1;98(1):1–9. doi: 10.1016/j.prevetmed.2010.08.00520869130
20. Garner MG, Beckett SD, Modelling the spread of foot-and-mouth disease in Australia. Aust Vet J. 2005;83(12):758–66. 16395942
21. Hagerman AD, McCarl BA, Carpenter TE, Ward MP, O’Brien J, Emergency vaccination to control foot-and-mouth disease: implications of its inclusion as a US policy option. Appl Econ Perspect Policy. 2012;34(1):119–46.
22. Porphyre T, Auty HK, Tildesley MJ, Gunn GJ, Woolhouse ME, Vaccination against foot-and-mouth disease: do initial conditions affect its benefit?PloS One. 2013;8(10):e77616. doi: 10.1371/journal.pone.007761624204895
23. Tildesley MJ, Bessell PR, Keeling MJ, Woolhouse ME, The role of pre-emptive culling in the control of foot-and-mouth disease. Proc R Soc Lond B Biol Sci. 2009;276:3239–48.
24. Tildesley MJ, Deardon R, Savill NJ, Bessell PR, Brooks SP, Woolhouse ME, et al. Accuracy of models for the 2001 foot-and-mouth epidemic. Proc R Soc Lond B Biol Sci. 2008Jun22;275(1641):1459–68.
25. Jamal SM, Bouma A, van den Broek J, Stegeman A, Chénard G, Dekker A, Foot-and-mouth disease vaccine potency testing: The influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose–response curve in cattle. Vaccine. 2008Nov25;26(50):6317–21. doi: 10.1016/j.vaccine.2008.09.02118822336
26. Carr BV, Lefevre EA, Windsor MA, Inghese C, Gubbins S, Prentice H, et al. CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle. J Gen Virol. 2013;94(Pt 1):97. doi: 10.1099/vir.0.045732-0
27. DEFRA. Foot and Mouth Disease Control Strategy for Great Britain. 2011.